Hypertrophic cardiomyopathy (HCM) is a genetic heart condition characterized by abnormal thickening of the heart muscle, particularly the left ventricle. This thickening can obstruct blood flow from the heart and make it harder for the heart to pump blood effectively, leading to symptoms like shortness of breath, chest pain, and arrhythmias. In medical ultrasound, specifically echocardiography, HCM is diagnosed by visualizing the hypertrophied myocardium, assessing ventricular function, and identifying any outflow tract obstruction.
Echocardiography is the primary imaging modality for HCM, providing detailed insights into myocardial wall thickness, chamber dimensions, and valvular function. Early and accurate diagnosis via cardiac ultrasound is crucial for guiding treatment strategies, including medication and, in some cases, surgical interventions, to improve patient outcomes and prevent serious complications such as sudden cardiac death.
